[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase
[Asia Economy Reporter Hwang Junho] Daebong LS is surging on news of a free capital increase by its subsidiary, P&K Skin Clinical Research Center.
As of 10:14 AM on the 12th, Daebong LS is trading at 8,790 KRW, up 16.27% from the previous day.
On the same morning, P&K Skin Clinical Research Center announced a decision to issue three free shares for every one common share. Trading of this stock was suspended for 30 minutes from the time of the announcement due to the disclosure of major matters.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Daebong LS is the largest shareholder, holding 54.74% of P&K Skin Clinical Research Center's shares.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.